Skip to main content

Table 2 Outcomes of the clinical trials included in the meta-analysis

From: The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis

Study

Sample size (n)

HCV genotype (n)

End of treatment

End of follow-up

    

HCV ETVR (n)

ALT normalization (n)

HCV SVR (n)

HCV relapse (n)

ALT normalization (n)

  

Genotype 1

Non- genotype 1

Overall

Genotype 1

Non-genotype 1

 

Overall

Genotype 1

Non-genotype 1

Overall

Genotype 1

Non-genotype 1

 

Yu et al. [35]

C: 50

30

20

46

27

19

NR

27

12

15

19

15

4

NR

 

M: 46

25

21

32

14

18

NR

26

11

15

6

3

3

NR

Liu et al. [32]

C: 161

97

64

138

82

56

NR

123

70

53

15

12

3

103

 

M: 160

110

50

141

95

46

NR

127

85

42

14

10

4

122

Chuang et al. [34]

C: 42

21

21

NR

NR

NR

NR

29

10

19

NR

NR

NR

23

 

M: 84

48

36

NR

NR

NR

NR

54

39

15

NR

NR

NR

51

Hung et al. [30]

C: 36

17

19

33

NR

NR

24

25

10

15

8

NR

NR

20

 

M: 72

34

38

68

NR

NR

66

51

18

33

17

NR

NR

52

Liu et al. [36]

C: 24

14

7

16

10

6

12

9

3

6

7

NR

NR

9

 

M: 30

17

13

25

NR

NR

23

18

NR

NR

5

NR

NR

18

  1. C HBV and HCV coinfection, M HCV mono-infection, NR not reported.